1. Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells
    Qingxia Zhao et al, 2016, International Journal of Oncology CrossRef
  2. An okadaic acid fragment analogue prevents nicotine-induced resistance to cisplatin by recovering PP2A activity in non-small cell lung cancer cells
    Raquel L. Arribas et al, 2020, Bioorganic Chemistry CrossRef
  3. Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
    Chen Xue et al, 2021, Signal Transduction and Targeted Therapy CrossRef
  4. CIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine
    Peng Xu et al, 2016, Oncotarget CrossRef
  5. The role of CIP2A as a therapeutic target of rapamycin in radioresistant head and neck cancer with TP53 mutation
    Song Hee Kim et al, 2019, Head & Neck CrossRef
  6. From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer
    Beibei Chen et al, 2023, Frontiers in Genetics CrossRef
  7. Integrative assessment of CIP2A overexpression and mutational effects in human malignancies identifies possible deleterious variants
    Mohammad M. Tarek et al, 2021, Computers in Biology and Medicine CrossRef
  8. Cancerous Inhibitor of PP2A Silencing Inhibits Proliferation and Promotes Apoptosis in Human Multiple Myeloma Cells
    Xi Yang et al, 2016, BioMed Research International CrossRef
  9. Paired Expression Analysis of Tumor Cell Surface Antigens
    Rimas J. Orentas et al, 2017, Frontiers in Oncology CrossRef
  10. CIP2A interacts with AKT1 to promote the malignant biological behaviors of oral squamous cell carcinoma by upregulating the GSK‑3β/β‑catenin pathway
    Yilei Che et al, 2023, Experimental and Therapeutic Medicine CrossRef
  11. Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line
    Hisham Saafan et al, 2021, Cells CrossRef
  12. Is Nucleoredoxin a Master Regulator of Cellular Redox Homeostasis? Its Implication in Different Pathologies
    Osiris Germán Idelfonso-García et al, 2022, Antioxidants CrossRef
  13. MicroRNA‑383‑5p inhibits the proliferation and promotes the apoptosis of gastric cancer cells by targeting cancerous inhibitor of PP2A
    Xinxin Li et al, 2020, International Journal of Molecular Medicine CrossRef
  14. CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML
    Claire M. Lucas et al, 2018, Blood Advances CrossRef
  15. MicroRNA-383-5p acts as a prognostic marker and inhibitor of cell proliferation in lung adenocarcinoma by cancerous inhibitor of protein phosphatase 2A
    Shasha Zhao et al, 2017, Oncology Letters CrossRef
  16. Downregulation of CIP2A inhibits cancer cell proliferation and vascularization in renal clear cell carcinoma
    Hui Gao et al, 2020, Biomedical Papers CrossRef